Finding studies

Clareo Health | Olaparib and Durvalumab (MEDI4736) in Patients with Metastatic Pancreatic Cancer and DNA Damage Repair Genes Alterations

Olaparib and Durvalumab (MEDI4736) in Patients with Metastatic Pancreatic Cancer and DNA Damage Repair Genes Alterations

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study